Oragenics Files 8-K with Corporate Updates

Ticker: OGEN · Form: 8-K · Filed: Aug 21, 2024 · CIK: 1174940

Sentiment: neutral

Topics: corporate-filing, 8-k, sec-filing

TL;DR

Oragenics filed an 8-K on 8/21/24 detailing corporate info, no major news.

AI Summary

Oragenics, Inc. filed an 8-K on August 21, 2024, reporting other events and financial statements. The filing details the company's corporate structure, including its state of incorporation (FL), IRS number (593410522), and principal executive offices located at 1990 Main Street, Suite 750, Sarasota, FL 34236. The report also includes its SEC file number (001-32188) and film number (241227270).

Why It Matters

This 8-K filing provides essential corporate information and updates for Oragenics, Inc., which is important for investors and stakeholders to understand the company's official reporting status and administrative details.

Risk Assessment

Risk Level: low — The filing is a routine corporate update and does not contain information about significant financial events, strategic changes, or material risks.

Key Players & Entities

FAQ

What is the primary purpose of this Form 8-K filing for Oragenics, Inc.?

The Form 8-K filing on August 21, 2024, is for reporting 'Other Events' and 'Financial Statements and Exhibits' as per SEC regulations.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on August 21, 2024.

Where are Oragenics, Inc.'s principal executive offices located?

Oragenics, Inc.'s principal executive offices are located at 1990 Main Street, Suite 750, Sarasota, FL 34236.

What is Oragenics, Inc.'s Commission File Number?

Oragenics, Inc.'s Commission File Number is 001-32188.

In which state is Oragenics, Inc. incorporated?

Oragenics, Inc. is incorporated in Florida (FL).

Filing Stats: 447 words · 2 min read · ~1 pages · Grade level 11.2 · Accepted 2024-08-21 08:30:09

Filing Documents

SIGNATURES

SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 21 st day of August, 2024. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing